acquisition
Roche to acquire Carmot Therapeutics for $2.7bn
December 4, 2023Business Services Obesity, Roche, acquisition, diabetes
Roche has announced that it has entered into a definitive merger agreement with Carmot Therapeutics, in which it will acquire …
AbbVie to acquire ImmunoGen for approximately $10.1bn
December 1, 2023Sales and Marketing AbbVie, Oncology, acquisition
AbbVie and ImmunoGen have announced that AbbVie will acquire ImmunoGen and its lead cancer therapy Elahere (mirvetuximab soratansine-gynx), a first …
Syncona to acquire Freeline Therapeutics for $28.3m
November 24, 2023Business Services Freeline Therapeutics, Pharmacy, acquisition, syncona
Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …
Merck to acquire Caraway Therapeutics for up to $610m
November 22, 2023Business Services Caraway Therapeutics, MSD, Merck, Pharmacy, acquisition
Merck (known as MSD outside of the US and Canada) and Caraway Therapeutics have announced that they have entered into …
Astellas Pharma to acquire Propella Therapeutics for $175m
November 20, 2023Business Services Astellas Pharma, Oncology, Properlla Therapeutics, acquisition
Astellas Pharma and Propella Therapeutics have announced that Astellas and Propella have entered a merger agreement in which Astellas will …
Prange Group and Adragos Pharma to acquire Fresenius Kabi’s manufacturing site
November 16, 2023Business Services Fresenius Kabi, Pharmacy, Prange Group, acquisition
Prange Group and Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for their acquisition of its …
BMS acquires Mirati Therapeutics for $4.8bn
October 9, 2023Business Services BMS, Mirati Therapeutics, Oncology, acquisition, bristol myers squibb, oncology
Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a definitive agreement under which BMS …
Eli Lilly to acquire POINT Biopharma
October 4, 2023Business Services Eli Lilly, Oncology, POINT Biopharma, acquisition, oncology
Eli Lilly and POINT Biopharma have announced a definitive agreement for Lilly to acquire POINT to expand its pipeline of …
Alfasigma to acquire Intercept Pharmaceuticals for $19 per share
September 27, 2023Business Services Alfasigma, Gastrointestinal tract, acquisition
Alfasigma and Intercept Pharmaceuticals have announced that they have entered into a definitive merger agreement, meaning Alfasigma will acquire Intercept …
Pharmanovia acquires CNS portfolio from Sanofi
September 20, 2023Medical Communications CNS, Neurology, Pharmanovia, Sanofi, acquisition
Pharmanovia has announced that it will expand its neurology portfolio with the acquisition of a selection of central nervous system …
Abbott to acquire Bigfoot Biomedical
September 6, 2023Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
Novo Nordisk acquires Embark Biotech and its lead metabolic programme
August 31, 2023Business Services Cardiology, Novo Nordisk, Obesity, acquisition, metabolics, obesity
Novo Nordisk has officially acquired the biopharmaceutical company Embark Biotech, along with its lead asset metabolic programme. The teams will …
LEO Pharma to acquire Timber Pharmaceuticals for up to $36m
August 22, 2023Business Services Dermatology, LEO Pharma, Timber Pharmaceuticals, acquisition
Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by LEO Pharma, with a total …
Biogen to acquire Reata Pharmaceuticals
July 31, 2023Business Services Biogen, Neurology, Reata Pharmaceuticals, acquisition
Biogen and Reata Pharmaceuticals have announced that they have entered a definitive agreement under which Biogen will acquire Reata for …
Eli Lilly to acquire Versanis Bio for $1.9bn
July 17, 2023Sales and Marketing Cardiology, Eli Lilly, Versanis Bio, acquisition, cardiometabolic diseases
Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
